Dr. JORDAENS: what changed
What changed
Dr. JORDAENS
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Net result for the year
€109,059
2024 · €146,095-€37,036
Equity
€531,225
2024 · €461,596+€69,629
Cash
€31,082
2024 · €26,461+€4,621
Balance sheet total
€617,602
2024 · €516,991+€100,612
Largest movements
Assets
- Current investments +€63,818
up €63,818 (+25.4%), from €250,927 to €314,744
- Receivables within one year +€26,712
up €26,712 (+38.7%), from €69,065 to €95,777
of which Other amounts receivable: +€25,727
Equity and liabilities
- Reserves +€215,724
up €215,724 (+71.6%), from €301,242 to €516,965
- Profit (loss) carried forward -€146,095
no longer reported in 2025 (was €146,095)
- Tax, wage and social debts +€18,806
up €18,806 (+91.1%), from €20,633 to €39,439
of which Taxes: +€18,306
- Accrued charges and deferred income +€13,745
up €13,745 (+43.0%), from €31,974 to €45,719
Income statement
- Gross operating margin -€36,158
down €36,158 (-18.4%), from €197,004 to €160,846
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€146,095
Gross operating margin
-€36,158
Depreciation
+€901
Other operating charges
+€118
Financial income
+€890
Financial charges
-€861
Taxes
-€1,927
Result 2025
€109,059
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€111,588
Investment
-€67,537
Financing
-€39,430
Cash 2024
€26,461
From operations (derived)
+€111,588
Net result for the year
+€109,059
Depreciation
+€3,427
Receivables within one year
-€26,712
Deferred charges and accrued income
-€5,169
Trade debts
-€1,568
Tax, wage and social debts
+€18,806
Accrued charges and deferred income
+€13,745
Investment (derived)
-€67,537
Investment in fixed assets (net)
-€3,719
Current investments
-€63,818
Financing
-€39,430
Contributions, distributions and other
-€39,430
Cash 2025
€31,082
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €516,991 | €617,602 | +€100,612 | +19.5% |
| Fixed assets | 21/28 | €21,334 | €21,626 | +€292 | +1.4% |
| Tangible fixed assets | 22/27 | €20,709 | €21,001 | +€292 | +1.4% |
| Plant, machinery and equipment | 23 | €1,891 | €1,208 | -€683 | -36.1% |
| Furniture and vehicles | 24 | €9,012 | €9,215 | +€203 | +2.3% |
| Other tangible fixed assets | 26 | €9,807 | €10,578 | +€772 | +7.9% |
| Financial fixed assets | 28 | €625 | €625 | = | 0.0% |
| Current assets | 29/58 | €495,657 | €595,976 | +€100,320 | +20.2% |
| Amounts receivable within one year | 40/41 | €69,065 | €95,777 | +€26,712 | +38.7% |
| Trade receivables | 40 | €654 | €1,639 | +€985 | +151% |
| Other amounts receivable | 41 | €68,411 | €94,138 | +€25,727 | +37.6% |
| Current investments | 50/53 | €250,927 | €314,744 | +€63,818 | +25.4% |
| Cash at bank and in hand | 54/58 | €26,461 | €31,082 | +€4,621 | +17.5% |
| Deferred charges and accrued income | 490/1 | €149,205 | €154,373 | +€5,169 | +3.5% |
| Total equity and liabilities | 10/49 | €516,991 | €617,602 | +€100,612 | +19.5% |
| Equity | 10/15 | €461,596 | €531,225 | +€69,629 | +15.1% |
| Contributions | 10/11 | €14,260 | €14,260 | = | 0.0% |
| Reserves | 13 | €301,242 | €516,965 | +€215,724 | +71.6% |
| Distributable reserves | 133 | €301,242 | €516,965 | +€215,724 | +71.6% |
| Profit (loss) carried forward | 14 | €146,095 | - | -€146,095 | |
| Amounts payable | 17/49 | €55,394 | €86,377 | +€30,983 | +55.9% |
| Amounts payable within one year | 42/48 | €23,420 | €40,658 | +€17,238 | +73.6% |
| Trade debts | 44 | €2,788 | €1,220 | -€1,568 | -56.2% |
| Suppliers | 440/4 | €2,788 | €1,220 | -€1,568 | -56.2% |
| Taxes, remuneration and social security | 45 | €20,633 | €39,439 | +€18,806 | +91.1% |
| Taxes | 450/3 | €20,633 | €38,939 | +€18,306 | +88.7% |
| Remuneration and social security | 454/9 | - | €500 | +€500 | |
| Accrued charges and deferred income | 492/3 | €31,974 | €45,719 | +€13,745 | +43.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,328 | €3,427 | -€901 | -20.8% |
| Other operating charges | 640/8 | €844 | €726 | -€118 | -14.0% |
| Gross operating margin | 9900 | €197,004 | €160,846 | -€36,158 | -18.4% |
| Operating profit (loss) | 9901 | €191,832 | €156,693 | -€35,139 | -18.3% |
| Financial income | 75/76B | €5,455 | €6,345 | +€890 | +16.3% |
| Recurring financial income | 75 | €5,455 | €6,345 | +€890 | +16.3% |
| Financial charges | 65/66B | €1,017 | €1,878 | +€861 | +84.6% |
| Recurring financial charges | 65 | €1,017 | €1,878 | +€861 | +84.6% |
| Profit (loss) for the period before taxes | 9903 | €196,269 | €161,160 | -€35,109 | -17.9% |
| Income taxes | 67/77 | €50,174 | €52,101 | +€1,927 | +3.8% |
| Profit (loss) for the period | 9904 | €146,095 | €109,059 | -€37,036 | -25.4% |
| Profit (loss) for the period to be appropriated | 9905 | €146,095 | €109,059 | -€37,036 | -25.4% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.